Intensity-modulated Radiation Therapy From 70Gy to 80Gy in Localized Prostate Cancer

Completed

• Conditions: Prostate Cancer

• Registration Number: NCT02974231
• Lead Sponsor: Institut de Cancérologie de Lorraine

Brief Summary

The objective is to report outcomes,including grade ≥2 overall late rectal and urinary toxicity and biochemical control rates in patients treated with IMRT (70 gy, 74 Gy and 80 Gy)

Detailed Description

Not available

Study Timeline

• Study Start: 2014-12
• Primary Completion: 2015-03
• Study Completion: 2015-03
• Status Verified: 2016-10
• Study First Submitted: 2016-10-10
• Study First Submitted QC: 2016-11-25
• Last Update Submitted: 2016-11-25
• Study First Posted: 2016-11-28
• Last Update Posted: 2016-11-28

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 240

Inclusion Criteria

Consecutive patients from June 2000 to December 2010 with

• untreated histologically confirmed adenocarcinoma of the prostate
• stage T1c-T4 N0 M0 according to the 1992 American Joint Committee on Cancer staging system

Exclusion Criteria

• Patients with positive pelvic lymphadenectomy or radiological positives nodes

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
grade≥ 2 overall late rectal 5 years after the end of radiotherapy	60 months